Exhausted T cells can be resurrected

By The Science Advisory Board staff writers

August 8, 2022 -- Even the most exhausted T cells can be revived, according to University of Pittsburgh and University of Pittsburgh Medical Center researchers. Previously, it was thought when T cells reached a certain stage of exhaustion they were done, but a study published August 5 in Science Immunology shows that's not the case.

The researchers profiled molecular features of T cells as they progressed from early to terminal exhaustion in a mouse model of melanoma. They found even the most terminally exhausted T cells retain some capacity to be functional again and they pinpointed approaches to overcome exhaustion.

In exhausted T cells with epigenomes damaged beyond repair, large portions of DNA had an open structure, suggesting there should be active gene expression in those areas. However, genes were not turned on in those areas, meaning something else was inhibiting gene expression. In their study, the researchers discovered it was insufficient co-stimulation. When the researchers used an antibody that binds to the co-stimulatory receptor 4-1BB, gene expression increased and enhanced T cell activity.

They also discovered hypoxia was common in the tumor microenvironment and when T cells were reprogrammed to be resistant to hypoxia, they differentiated into a more functional state. Given these findings, drugs that target hypoxia, co-stimulation pathways, or engineering exhaustion-resistant CAR T cells, could improve cancer immunotherapy, according to the researchers.

Link between genes, mitochondrial DNA reveals way to tackle cardiovascular disease
The discovery of a link between mitochondria, inflammation, and a pair of genes that help regulate blood cell growth has revealed a potential new target...
First full map of immune system connections unlocks drug discovery opportunities
Researchers have created the first full map of immune system connections showing how immune cells communicate, pointing to ways to modulate the pathways...
New technique could enable production of generic CAR T cells at scale
A Boston Children’s Hospital lab has developed a new method that could make chimeric antigen receptor (CAR) T-cell therapy more widely available using...
Thymus uses RNA molecules to generate list of friendly proteins that T cells should not attack
Research from Cold Spring Harbor Laboratory has identified the RNA molecules used by the human thymus organ to generate a list of friendly proteins that...
Map of brain changes in Alzheimer’s reveals potential target cell for drug therapies
A National Institute of Aging-backed project has released large-scale cellular and molecular information taken from more than 1.2 million neurons and...

Copyright © 2022 scienceboard.net

Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter